100 related articles for article (PubMed ID: 30015904)
1. miR‑140‑5p regulates cell migration and invasion of non‑small cell lung cancer cells through targeting VEGFA.
Yang P; Xiong J; Zuo L; Liu K; Zhang H
Mol Med Rep; 2018 Sep; 18(3):2866-2872. PubMed ID: 30015904
[TBL] [Abstract][Full Text] [Related]
2. MicroRNA-661 promotes non-small cell lung cancer progression by directly targeting RUNX3.
Wang Y; Li Y; Wu B; Shi C; Li C
Mol Med Rep; 2017 Aug; 16(2):2113-2120. PubMed ID: 28656235
[TBL] [Abstract][Full Text] [Related]
3. miR‑140‑5p inhibits the proliferation of multiple myeloma cells by targeting VEGFA.
Liu M; Liu H; Zhou J; Yu Z
Mol Med Rep; 2021 Jan; 23(1):. PubMed ID: 33200797
[TBL] [Abstract][Full Text] [Related]
4. miR-202 functions as a tumor suppressor in non-small cell lung cancer by targeting STAT3.
Zhao Z; Lv B; Zhang L; Zhao N; Lv Y
Mol Med Rep; 2017 Aug; 16(2):2281-2289. PubMed ID: 28656198
[TBL] [Abstract][Full Text] [Related]
5. MicroRNA‑214 upregulates HIF‑1α and VEGF by targeting ING4 in lung cancer cells.
Li Y; Zhao L; Qi Y; Yang X
Mol Med Rep; 2019 Jun; 19(6):4935-4945. PubMed ID: 31059086
[TBL] [Abstract][Full Text] [Related]
6. MicroRNA-454 inhibits non‑small cell lung cancer cells growth and metastasis via targeting signal transducer and activator of transcription-3.
Liu S; Ge X; Su L; Zhang A; Mou X
Mol Med Rep; 2018 Mar; 17(3):3979-3986. PubMed ID: 29286124
[TBL] [Abstract][Full Text] [Related]
7. miR-577 suppresses cell proliferation and epithelial-mesenchymal transition by regulating the WNT2B mediated Wnt/β-catenin pathway in non-small cell lung cancer.
Wang B; Sun L; Li J; Jiang R
Mol Med Rep; 2018 Sep; 18(3):2753-2761. PubMed ID: 30015869
[TBL] [Abstract][Full Text] [Related]
8. MicroRNA-29c inhibits proliferation and promotes apoptosis in non-small cell lung cancer cells by targeting VEGFA.
Zhan S; Wang C; Yin F
Mol Med Rep; 2018 May; 17(5):6705-6710. PubMed ID: 29512752
[TBL] [Abstract][Full Text] [Related]
9. microRNA-128 plays a critical role in human non-small cell lung cancer tumourigenesis, angiogenesis and lymphangiogenesis by directly targeting vascular endothelial growth factor-C.
Hu J; Cheng Y; Li Y; Jin Z; Pan Y; Liu G; Fu S; Zhang Y; Feng K; Feng Y
Eur J Cancer; 2014 Sep; 50(13):2336-50. PubMed ID: 25001183
[TBL] [Abstract][Full Text] [Related]
10. MiR-182 inhibits the epithelial to mesenchymal transition and metastasis of lung cancer cells by targeting the Met gene.
Li Y; Zhang H; Li Y; Zhao C; Fan Y; Liu J; Li X; Liu H; Chen J
Mol Carcinog; 2018 Jan; 57(1):125-136. PubMed ID: 28940757
[TBL] [Abstract][Full Text] [Related]
11. miR‑140‑5p regulates angiogenesis following ischemic stroke by targeting VEGFA.
Sun J; Tao S; Liu L; Guo D; Xia Z; Huang M
Mol Med Rep; 2016 May; 13(5):4499-505. PubMed ID: 27035554
[TBL] [Abstract][Full Text] [Related]
12. MicroRNA‑629 inhibition suppresses the viability and invasion of non‑small cell lung cancer cells by directly targeting RUNX3.
Zhuang B; Cheng Y
Mol Med Rep; 2019 May; 19(5):3933-3940. PubMed ID: 30816536
[TBL] [Abstract][Full Text] [Related]
13. MiR-320a-3p/ELF3 axis regulates cell metastasis and invasion in non-small cell lung cancer via PI3K/Akt pathway.
Zhao W; Sun Q; Yu Z; Mao S; Jin Y; Li J; Jiang Z; Zhang Y; Chen M; Chen P; Chen D; Xu H; Ding S; Yu Z
Gene; 2018 Sep; 670():31-37. PubMed ID: 29803922
[TBL] [Abstract][Full Text] [Related]
14. A novel pathway in NSCLC cells: miR‑191, targeting NFIA, is induced by chronic hypoxia, and promotes cell proliferation and migration.
Zhao J; Qiao CR; Ding Z; Sheng YL; Li XN; Yang Y; Zhu DY; Zhang CY; Liu DL; Wu K; Zhao S
Mol Med Rep; 2017 Mar; 15(3):1319-1325. PubMed ID: 28075452
[TBL] [Abstract][Full Text] [Related]
15. MicroRNA-92a promotes epithelial-mesenchymal transition through activation of PTEN/PI3K/AKT signaling pathway in non-small cell lung cancer metastasis.
Lu C; Shan Z; Hong J; Yang L
Int J Oncol; 2017 Jul; 51(1):235-244. PubMed ID: 28534966
[TBL] [Abstract][Full Text] [Related]
16. MiR-195 is a key negative regulator of hepatocellular carcinoma metastasis by targeting FGF2 and VEGFA.
Wang M; Zhang J; Tong L; Ma X; Qiu X
Int J Clin Exp Pathol; 2015; 8(11):14110-20. PubMed ID: 26823724
[TBL] [Abstract][Full Text] [Related]
17. Tumor suppressor microRNA‑613 inhibits glioma cell proliferation, invasion and angiogenesis by targeting vascular endothelial growth factor A.
Yu X; Wang W
Mol Med Rep; 2017 Nov; 16(5):6729-6735. PubMed ID: 28901424
[TBL] [Abstract][Full Text] [Related]
18. MicroRNA-410 promotes cell proliferation by targeting BRD7 in non-small cell lung cancer.
Li D; Yang Y; Zhu G; Liu X; Zhao M; Li X; Yang Q
FEBS Lett; 2015 Aug; 589(17):2218-23. PubMed ID: 26149213
[TBL] [Abstract][Full Text] [Related]
19. MiR-142-3p functions as a potential tumor suppressor directly targeting HMGB1 in non-small-cell lung carcinoma.
Xiao P; Liu WL
Int J Clin Exp Pathol; 2015; 8(9):10800-7. PubMed ID: 26617792
[TBL] [Abstract][Full Text] [Related]
20. High expression of kinesin light chain-2, a novel target of miR-125b, is associated with poor clinical outcome of elderly non-small-cell lung cancer patients.
Wang M; Zhu X; Sha Z; Li N; Li D; Chen L
Br J Cancer; 2015 Mar; 112(5):874-82. PubMed ID: 25668010
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]